{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:49:47Z","timestamp":1790858987369,"version":"4.1.0"},"reference-count":54,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"unspecified","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"MRFF\/NHMRC","award":["1169868"],"award-info":[{"award-number":["1169868"]}]},{"name":"NHMRC Centre for Research Excellence","award":["1169868"],"award-info":[{"award-number":["1169868"]}]},{"name":"NHMRC Centre for Research Excellence","award":["1170958"],"award-info":[{"award-number":["1170958"]}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","award":["1154302"],"award-info":[{"award-number":["1154302"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","award":["1158111"],"award-info":[{"award-number":["1158111"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2022,4,20]]},"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Primary ciliary dyskinesia (PCD) is a rare, progressive, inherited ciliopathic disorder, which is incurable and frequently complicated by the development of bronchiectasis. There are few randomised controlled trials (RCTs) involving children and adults with PCD and thus evidence of efficacy for interventions are usually extrapolated from people with cystic fibrosis. Our planned RCT seeks to address some of these unmet needs by employing a currently prescribed (but unapproved for long-term use in PCD) macrolide antibiotic (azithromycin) and a novel mucolytic agent (erdosteine). The primary aim of our RCT is to determine whether regular oral azithromycin and erdosteine over a 12-month period reduces acute respiratory exacerbations among children and adults with PCD. Our primary hypothesis is that: people with PCD who regularly use oral azithromycin and\/or erdosteine will have fewer exacerbations than those receiving the corresponding placebo medications. Our secondary aims are to determine the effect of the trial medications on PCD-specific quality-of-life (QoL) and other clinical outcomes (lung function, time-to-next exacerbation, hospitalisations) and nasopharyngeal bacterial carriage and antimicrobial resistance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>We are currently undertaking a multicentre, double-blind, double-dummy RCT to evaluate whether 12\u2009months of azithromycin and\/or erdosteine is beneficial for children and adults with PCD. We plan to recruit 104 children and adults with PCD to a parallel, 2\u00d72 partial factorial superiority RCT at five sites across Australia. Our primary endpoint is the rate of exacerbations over 12\u2009months. Our main secondary outcomes are QoL, lung function and nasopharyngeal carriage by respiratory bacterial pathogens and their associated azithromycin resistance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>Our RCT is conducted in accordance with Good Clinical Practice and the Australian legislation and National Health and Medical Research Council guidelines for ethical conduct of Research, including that for First Nations Australians.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>ACTRN12619000564156.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2022-001236","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T12:48:18Z","timestamp":1653310098000},"page":"e001236","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Reducing exacerbations in children and adults with primary ciliary dyskinesia using erdosteine and\/or azithromycin therapy (REPEAT trial): study protocol for a multicentre, double-blind, double-dummy, 2\u00d72 partial factorial, randomised controlled trial"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1331-3706","authenticated-orcid":false,"given":"Anne B","family":"Chang","sequence":"first","affiliation":[{"name":"Child Health Division and NHMRC Centre for Research Excellence in Paediatric Bronchiectasis (AusBREATHE), Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia"},{"name":"Australian Centre for Health Services Innovation, Queensland University of Technology, Brisbane, Queensland, Australia"},{"name":"Department of Respiratory Medicine, Queensland Children\u2019s Hospital, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy C","family":"Morgan","sequence":"additional","affiliation":[{"name":"Department of Health and Ageing, Concord Repatriation General Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L","family":"Duncan","sequence":"additional","affiliation":[{"name":"School of Life Course & Population Sciences, King\u2019s College London, London, UK"},{"name":"Department of Endocrinology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, UK"},{"name":"Australian Translational Genomics Centre, Queensland University of Technology, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D","family":"Chatfield","sequence":"additional","affiliation":[{"name":"Child Health Division and NHMRC Centre for Research Excellence in Paediatric Bronchiectasis (AusBREATHE), Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia"},{"name":"Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Schultz","sequence":"additional","affiliation":[{"name":"Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia"},{"name":"Department of Respiratory and Sleep Medicine, Perth Children\u2019s Hospital, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J","family":"Leo","sequence":"additional","affiliation":[{"name":"Australian Translational Genomics Centre, Queensland University of Technology, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle B","family":"McCallum","sequence":"additional","affiliation":[{"name":"Child Health Division and NHMRC Centre for Research Excellence in Paediatric Bronchiectasis (AusBREATHE), Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aideen M","family":"McInerney-Leo","sequence":"additional","affiliation":[{"name":"University of Queensland Diamantina Institute, The University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M","family":"McPhail","sequence":"additional","affiliation":[{"name":"Australian Centre for Health Services Innovation, Queensland University of Technology, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuejen","family":"Zhao","sequence":"additional","affiliation":[{"name":"Child Health Division and NHMRC Centre for Research Excellence in Paediatric Bronchiectasis (AusBREATHE), Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia"},{"name":"Health Gains Planning, Northern Territory Department of Health, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Kruljac","sequence":"additional","affiliation":[{"name":"PCD Australia Foundation, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi C","family":"Smith-Vaughan","sequence":"additional","affiliation":[{"name":"Child Health Division and NHMRC Centre for Research Excellence in Paediatric Bronchiectasis (AusBREATHE), Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S","family":"Morris","sequence":"additional","affiliation":[{"name":"Child Health Division and NHMRC Centre for Research Excellence in Paediatric Bronchiectasis (AusBREATHE), Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M","family":"Marchant","sequence":"additional","affiliation":[{"name":"Australian Centre for Health Services Innovation, Queensland University of Technology, Brisbane, Queensland, Australia"},{"name":"Department of Respiratory Medicine, Queensland Children\u2019s Hospital, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie T","family":"Yerkovich","sequence":"additional","affiliation":[{"name":"Child Health Division and NHMRC Centre for Research Excellence in Paediatric Bronchiectasis (AusBREATHE), Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia"},{"name":"Australian Centre for Health Services Innovation, Queensland University of Technology, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L","family":"Cook","sequence":"additional","affiliation":[{"name":"Australian Centre for Health Services Innovation, Queensland University of Technology, Brisbane, Queensland, Australia"},{"name":"Department of Respiratory Medicine, Queensland Children\u2019s Hospital, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Wurzel","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Royal Children\u2019s Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Versteegh","sequence":"additional","affiliation":[{"name":"Child Health Division and NHMRC Centre for Research Excellence in Paediatric Bronchiectasis (AusBREATHE), Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"O\u2019Farrell","sequence":"additional","affiliation":[{"name":"Child Health Division and NHMRC Centre for Research Excellence in Paediatric Bronchiectasis (AusBREATHE), Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia"},{"name":"Australian Centre for Health Services Innovation, Queensland University of Technology, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9078-2357","authenticated-orcid":false,"given":"Margaret S","family":"McElrea","sequence":"additional","affiliation":[{"name":"Australian Centre for Health Services Innovation, Queensland University of Technology, Brisbane, Queensland, Australia"},{"name":"Department of Respiratory Medicine, Queensland Children\u2019s Hospital, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Fletcher","sequence":"additional","affiliation":[{"name":"Australian Centre for Health Services Innovation, Queensland University of Technology, Brisbane, Queensland, Australia"},{"name":"Department of Respiratory Medicine, Queensland Children\u2019s Hospital, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"D'Antoine","sequence":"additional","affiliation":[{"name":"Child Health Division and NHMRC Centre for Research Excellence in Paediatric Bronchiectasis (AusBREATHE), Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enna","family":"Stroil-Salama","sequence":"additional","affiliation":[{"name":"Lung Foundation of Australia, Metro South Health, Brisbane, Queensland, Australia"},{"name":"Brisbane South Palliative Care Collaborative, Metro South, Queensland Health, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil J","family":"Robinson","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Royal Children\u2019s Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Grimwood","sequence":"additional","affiliation":[{"name":"Departments of Infectious Disease and Paediatrics, Gold Coast Health, Gold Coast, Queensland, Australia"},{"name":"School of Medicine and Dentistry, and Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,5,9]]},"reference":[{"key":"2025083112360953000_9.1.e001236.1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ppul.23304","article-title":"Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: pcd Foundation consensus recommendations based on state of the art review","volume":"51","author":"Shapiro","year":"2016","journal-title":"Pediatr Pulmonol"},{"key":"2025083112360953000_9.1.e001236.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31554-X"},{"key":"2025083112360953000_9.1.e001236.3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00051509"},{"key":"2025083112360953000_9.1.e001236.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.05.007"},{"key":"2025083112360953000_9.1.e001236.5","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2017.1360770"},{"key":"2025083112360953000_9.1.e001236.6","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(18)31723-9","article-title":"Amoxicillin-Clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial","volume":"392","author":"Goyal","year":"2018","journal-title":"Lancet"},{"key":"2025083112360953000_9.1.e001236.7","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S2213-2600(13)70185-1","article-title":"Long-Term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (bronchiectasis intervention study): a multicentre, double-blind, randomised controlled trial","volume":"1","author":"Valery","year":"2013","journal-title":"Lancet Respir Med"},{"key":"2025083112360953000_9.1.e001236.8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/jamp.2017.1443","article-title":"Impact of hypertonic saline solutions on sputum expectoration and their safety profile in patients with bronchiectasis: a randomized crossover trial","volume":"31","author":"Herrero-Cortina","year":"2018","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"2025083112360953000_9.1.e001236.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2004.05.006"},{"key":"2025083112360953000_9.1.e001236.10","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/ppul.23479","article-title":"Recovery of baseline lung function after pulmonary exacerbation in children with primary ciliary dyskinesia","volume":"51","author":"Sunther","year":"2016","journal-title":"Pediatr Pulmonol"},{"key":"2025083112360953000_9.1.e001236.11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200811-1731OC"},{"key":"2025083112360953000_9.1.e001236.12","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015285","article-title":"Meta-Analysis of macrolide maintenance therapy for prevention of disease exacerbations in patients with noncystic fibrosis bronchiectasis","volume":"98","author":"Wang","year":"2019","journal-title":"Medicine"},{"key":"2025083112360953000_9.1.e001236.13","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02990-2020"},{"key":"2025083112360953000_9.1.e001236.14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S2213-2600(20)30058-8","article-title":"Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial","volume":"8","author":"Kobbernagel","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2025083112360953000_9.1.e001236.15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3389\/fped.2020.00519","article-title":"Azithromycin prescribing by respiratory pediatricians in Australia and New Zealand for chronic wet cough: a questionnaire-based survey","volume":"8","author":"Chellew","year":"2020","journal-title":"Front Pediatr"},{"key":"2025083112360953000_9.1.e001236.16","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-016-0261-x","article-title":"Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6\u00a0months in primary ciliary dyskinesia","volume":"16","author":"Kobbernagel","year":"2016","journal-title":"BMC Pulm Med"},{"key":"2025083112360953000_9.1.e001236.17","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0042-3"},{"key":"2025083112360953000_9.1.e001236.18","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1164\/rccm.201802-0215OC","article-title":"Azithromycin for early Pseudomonas infection in cystic fibrosis. The optimize randomized trial","volume":"198","author":"Mayer-Hamblett","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2025083112360953000_9.1.e001236.19","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/ppul.24336","article-title":"Do combined upper airway cultures identify lower airway infections in children with chronic cough?","volume":"54","author":"Hare","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"2025083112360953000_9.1.e001236.20","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-015-2480-0"},{"key":"2025083112360953000_9.1.e001236.21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5694\/mja2.50216","article-title":"An urgent need for antimicrobial stewardship in Indigenous rural and remote primary health care","volume":"211","author":"Bowen","year":"2019","journal-title":"Med J Aust"},{"key":"2025083112360953000_9.1.e001236.22","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00003510"},{"key":"2025083112360953000_9.1.e001236.23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01770-2016"},{"key":"2025083112360953000_9.1.e001236.24","first-page":"133","article-title":"Erdosteine: a new therapeutic weapon beyond peace","volume":"12","author":"Cogo","year":"2012","journal-title":"Trends Med"},{"key":"2025083112360953000_9.1.e001236.25","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20344"},{"key":"2025083112360953000_9.1.e001236.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.09.003"},{"key":"2025083112360953000_9.1.e001236.27","unstructured":"Erdosteine received orphan drug status by the FDA, 2018. Available: www.prnewswire.co.uk\/news-releases\/erdosteine-received-orphan-drug-status-by-the-fda-256933201.html [Accessed 10th Oct 2021]."},{"key":"2025083112360953000_9.1.e001236.28","doi-asserted-by":"crossref","first-page":"402","DOI":"10.5414\/CPP38402","article-title":"A controlled multicenter pediatric study in the treatment of acute respiratory tract diseases with the aid of a new specific compound, erdosteine (IPSE, Italian pediatric study erdosteine)","volume":"38","author":"Titti","year":"2000","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2025083112360953000_9.1.e001236.29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5414\/CPP45016","article-title":"Clinical effects of erdosteine in the treatment of acute respiratory tract diseases in children","volume":"45","author":"Balli","year":"2007","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2025083112360953000_9.1.e001236.30","doi-asserted-by":"crossref","DOI":"10.14238\/pi51.2.2011.111-5","article-title":"Randomized controlled trial of erdosteine for acute cough in children with colds","volume":"51","author":"Yenny","year":"2011","journal-title":"Paediatr Indones"},{"key":"2025083112360953000_9.1.e001236.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2009.10.002"},{"key":"2025083112360953000_9.1.e001236.32","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01090-2016"},{"key":"2025083112360953000_9.1.e001236.33","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201805-0819ST"},{"key":"2025083112360953000_9.1.e001236.34","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12010129","article-title":"Axonemal symmetry break, a new ultrastructural diagnostic tool for primary ciliary dyskinesia?","volume":"12","author":"Blanco-M\u00e1\u00f1ez","year":"2022","journal-title":"Diagnostics"},{"key":"2025083112360953000_9.1.e001236.35","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00353-2021"},{"key":"2025083112360953000_9.1.e001236.36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5694\/j.1326-5377.2010.tb03396.x","article-title":"Single-Dose azithromycin versus seven days of amoxycillin in the treatment of acute otitis media in Aboriginal children (AATAAC): a double blind, randomised controlled trial","volume":"192","author":"Morris","year":"2010","journal-title":"Med J Aust"},{"key":"2025083112360953000_9.1.e001236.37","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01551-2015"},{"key":"2025083112360953000_9.1.e001236.38","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S2213-2600(21)00104-1","article-title":"Duration of amoxicillin-clavulanate for protracted bacterial bronchitis in children (DACS): a multi-centre, double blind, randomised controlled trial","volume":"9","author":"Ruffles","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2025083112360953000_9.1.e001236.39","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S2213-2600(19)30254-1","article-title":"Efficacy of oral antibiotics for non-severe exacerbations of bronchiectasis in children (best 1): a multi-centre, double-blind, double-dummy, randomised placebo-controlled trial","volume":"7","author":"Goyal","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2025083112360953000_9.1.e001236.40","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00147-2018"},{"key":"2025083112360953000_9.1.e001236.41","doi-asserted-by":"publisher","DOI":"10.1002\/pst.250"},{"key":"2025083112360953000_9.1.e001236.42","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1002\/sim.7322","article-title":"Economic evaluation of factorial randomised controlled trials: challenges, methods and recommendations","volume":"36","author":"Dakin","year":"2017","journal-title":"Stat Med"},{"key":"2025083112360953000_9.1.e001236.43","first-page":"143","article-title":"The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE study","volume":"30","author":"Moretti","year":"2004","journal-title":"Drugs Exp Clin Res"},{"key":"2025083112360953000_9.1.e001236.44","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212468"},{"key":"2025083112360953000_9.1.e001236.45","doi-asserted-by":"publisher","DOI":"10.1378\/chest.113.5.1329"},{"key":"2025083112360953000_9.1.e001236.46","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00122-2021"},{"key":"2025083112360953000_9.1.e001236.47","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/resp.13828","article-title":"Cost of hospitalization for bronchiectasis exacerbation in children","volume":"25","author":"Goyal","year":"2020","journal-title":"Respirology"},{"key":"2025083112360953000_9.1.e001236.48","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-019-4414-5","article-title":"Health-resource use and quality of life in children with bronchiectasis: a multi-center pilot cohort study","volume":"19","author":"Lovie-Toon","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"2025083112360953000_9.1.e001236.49","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21518"},{"key":"2025083112360953000_9.1.e001236.50","first-page":"1726","article-title":"Primary ciliary dyskinesia: first health-related quality-of-life measures for pediatric patients","volume":"13","author":"Dell","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2025083112360953000_9.1.e001236.51","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-209356"},{"key":"2025083112360953000_9.1.e001236.52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpeds.2020.05.052","article-title":"Clinical and genetic spectrum of children with primary ciliary dyskinesia in China","volume":"225","author":"Guo","year":"2020","journal-title":"J Pediatr"},{"key":"2025083112360953000_9.1.e001236.53","first-page":"00009-1","article-title":"Primary ciliary dyskinesia: a big data genomics approach","volume":"S2213-2600","author":"Mitchison","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2025083112360953000_9.1.e001236.54","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/1753-6405.13168","article-title":"Respiratory virus detection during the COVID-19 pandemic in Queensland, Australia","volume":"46","author":"El-Heneidy","year":"2022","journal-title":"Aust N Z J Public Health"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2022-001236","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T19:36:21Z","timestamp":1756668981000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2022-001236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,5,9]]},"published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1136\/bmjresp-2022-001236"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2022-001236","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5]]}}}